AbbVie Inc.

VANGUARD GROUP INC ABBV

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

180,779,699

Value ($000)

41,306,353

Weight

0.6%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	41,306,353	0.6%	180,779,699	12/31/2025
2025 Q3	11/7/2025	41,155,601	0.6%	177,747,261	9/30/2025
2025 Q2	8/11/2025	32,910,186	0.5%	177,298,707	6/30/2025
2025 Q1	5/9/2025	36,439,271	0.7%	173,917,865	3/31/2025
2024 Q4	2/11/2025	30,754,908	0.5%	173,072,078	12/31/2024
2024 Q3	11/13/2024	33,897,016	0.6%	171,647,841	9/30/2024
2024 Q2	8/13/2024	29,271,525	0.6%	170,659,546	6/30/2024
2024 Q1	5/10/2024	31,025,605	0.6%	170,376,746	3/31/2024
2023 Q4	3/11/2024	24,856,929	0.5%	160,398,331	12/31/2023
2023 Q3	12/18/2023	23,961,001	0.6%	160,747,355	9/30/2023
2023 Q2	8/14/2023	21,462,121	0.5%	159,297,266	6/30/2023
2023 Q1	7/14/2023	25,573,522	0.7%	160,466,347	3/31/2023
2022 Q4	2/10/2023	25,585,700	0.7%	158,317,552	12/31/2022
2022 Q3	11/14/2022	20,939,769	0.6%	156,022,414	9/30/2022
2022 Q2	8/12/2022	23,522,275	0.7%	153,579,751	6/30/2022
2022 Q1	5/13/2022	24,400,600	0.6%	150,518,780	3/31/2022
2021 Q4	2/14/2022	19,810,654	0.4%	146,312,069	12/31/2021
2021 Q3	11/12/2021	15,698,269	0.4%	145,529,515	9/30/2021
2021 Q2	8/13/2021	16,298,283	0.4%	144,693,566	6/30/2021
2021 Q1	5/14/2021	15,554,888	0.4%	143,733,946	3/31/2021
2020 Q4	2/12/2021	15,275,634	0.4%	142,563,074	12/31/2020
2020 Q3	11/16/2020	12,642,290	0.4%	144,334,850	9/30/2020
2020 Q2	8/14/2020	14,470,438	0.5%	147,386,808	6/30/2020
2020 Q1	5/15/2020	9,569,509	0.4%	125,600,569	3/31/2020
2019 Q4	2/14/2020	10,852,765	0.4%	122,574,720	12/31/2019
2014 Q2	8/11/2014	4,837,942	0.4%	85,718,309	6/30/2014
2014 Q1	5/13/2014	4,331,089	0.4%	84,262,435	3/31/2014
2013 Q4	2/12/2014	4,345,008	0.4%	82,276,225	12/31/2013